Pharmacist Led Intervention in the Management of Anemia Among Pregnant Woman

NCT07800611 | Not Yet Recruiting

• 1 other identifier: ERC-FoP-2023-007
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Anemia is a major public health problem among pregnant women, particularly in low- and middle-income countries. It is characterized by a reduction in hemoglobin concentration or the oxygen-carrying capacity of the blood, which may be insufficient to meet the physiological needs of the body. Maternal anemia is associated with an increased risk of adverse maternal and fetal outcomes. Despite the high prevalence of anemia among pregnant women, poor medication adherence and inadequate understanding of prescribed therapy may limit treatment effectiveness. Pharmacists can play an important role in providing medication-related education, improving patients' understanding of their treatment, identifying barriers to adherence, and promoting appropriate medication use. However, evidence on pharmacist-led educational interventions to improve medication adherence and hemoglobin levels among anemic pregnant women in Pakistan remains limited. Therefore, this randomized controlled trial will be conducted to evaluate the effect of a structured pharmacist-led educational intervention on medication adherence and hemoglobin levels among anemic pregnant women in District Chakwal, Punjab, Pakistan. A total of 100 eligible pregnant women diagnosed with anemia will be recruited and randomly allocated into intervention and control groups. Participants in the intervention group will receive a structured pharmacist-led educational intervention in addition to routine care, while participants in the control group will receive routine antenatal care and standard anemia management. Medication adherence and hemoglobin levels will be assessed at baseline and after the intervention. The study will determine whether pharmacist-led educational counseling improves medication adherence and hemoglobin levels compared with routine care. Data will be analyzed using IBM SPSS Statistics version 26. A paired-sample t-test will be used to compare changes in continuous variables, particularly hemoglobin levels, between baseline and post-intervention assessments. McNemar's test will be used to assess changes in paired categorical variables, including medication adherence where appropriate. A p-value of \<0.05 will be considered statistically significant.

Conditions

Anemia Complicating Pregnancy

Keywords

Anemia; Pharmacist; intervention

Outcome Measures

Primary Outcomes (3)

• Change in hemoglobin concentration

  Description: Change in hemoglobin (Hb) concentration from baseline to one-month follow-up, measured in g/dL using a laboratory hemoglobin test.

  Baseline and one month after the pharmacist-led counseling intervention.

• Change in anemia severity

  Description: Change in anemia severity from baseline to one-month follow-up, categorized according to the participant's measured hemoglobin concentration using the predefined diagnostic criteria for anemia.

  Baseline and one month after the pharmacist-led counseling intervention.

• Medication adherence

  Description: Change in medication adherence from baseline to one-month follow-up, assessed using the \[name of your actual validated adherence scale/questionnaire\].

  Time Frame: Baseline and one month after the intervention.

Study Arms (1)

Pre and post evaluation

OTHER

Pharmacist-Led Anemia Counseling: Patients will receive individualized pharmacist-led counseling regarding anemia management, medication adherence, appropriate use of prescribed medicines, dietary measures, and strategies to improve quality of life. Outcomes will be assessed before the intervention and at one-month follow-up. Study Design: Single-arm, pre-post evaluation.

Other: Pharmacist-led counseling on anemia management

Interventions

Pharmacist-led counseling on anemia management OTHER

Intervention Description: Patients will receive individualized pharmacist-led counseling regarding anemia management, medication adherence, appropriate use of prescribed medicines, dietary measures, and strategies to improve quality of life. Outcomes will be assessed before the intervention and at one-month follow-up. Study Design: Single-arm, pre-post evaluation.

Also known as: Pharmacist-Led Anemia Counseling

Pre and post evaluation

Eligibility Criteria

• Gender Eligibility Details: 1. Pregnant woman 2. Hb \<11g/dl
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Pregnant woman
• Hb \<11g/dl
• Having Punjab domicile-

You may not qualify if:

• Patients with co-morbidities
• Patients with Hb \>11g/dl
• Outside the Punjab domicile

Sponsors & Collaborators

• Hamdard University: lead

Study Sites (1)

DHQ Chakwal

Islamabad, Islamabad, 45570, Pakistan

Location

Related Publications (1)

• Adje, D., et al. (2020). "Impact of pharmacists' health educational intervention on anemia in pregnancy in rural settings in Kano, Nigeria." Int. J. Pharm. Sci. Res 11: 2403-2410.

  RESULT

MeSH Terms

Conditions

Anemia

Condition Hierarchy (Ancestors)

Hematologic Diseases; Hemic and Lymphatic Diseases

Central Study Contacts

Muhammad Abubakar, PhD

CONTACT

00923237166544; mabubakar.pharmacist@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: August 18, 2026
• First Posted: September 2, 2026
• Study Start: September 10, 2026
• Primary Completion (Estimated): October 15, 2026
• Study Completion (Estimated): November 15, 2026
• Last Updated: September 2, 2026

Record last verified: 2026-08

Locations

PA (1)